NCT05541289 Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older Status NO_LONGER_AVAILABLE Phase N/A
NCT05539560 The Effect of Olfactory Training in Patients With COVID-19 Induced Olfactory Dysfunction Status RECRUITING Phase NA
NCT05539482 Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption of Self-Protective Measures of Hong Kong Residents Status RECRUITING Phase NA
NCT05534009 Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW) Status RECRUITING Phase N/A
NCT05533918 SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Text Message Study Status COMPLETED Phase NA
NCT05533359 SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study Status COMPLETED Phase NA
NCT05532995 Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise Network Status COMPLETED Phase N/A
NCT05532293 Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT05531149 Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia Status TERMINATED Phase PHASE3
NCT05531058 The Impact of a Web-based Psychoeducation Programme with a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy Status COMPLETED Phase NA
NCT05531006 Anesthesia Preferences in the COVID-19 Pandemic: General Anesthesia or Regional Anesthesia? Status COMPLETED Phase N/A
NCT05530317 CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19 Status TERMINATED Phase NA
NCT05529771 Clinical Outcomes of paTients pREsenting to HArare COVID-19 CenTer of Excellence With SARS-CoV-2 Infection Status COMPLETED Phase N/A
NCT05526183 Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine Status UNKNOWN Phase PHASE1
NCT05525208 Booster Study of COVID-19 Protein Subunit Recombinant Vaccine Status COMPLETED Phase PHASE2
NCT05525182 Efficacy and Safety of ES16001 in Patients With COVID-19 Status UNKNOWN Phase PHASE2/PHASE3